LENZ Therapeutics Inc.

LENZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.08

+$0.01 (+0.25%)

At close: Sep 21, 2026, 4:00 PM ET

$4.11

+$0.03 (+0.74%)

Pre-market: Sep 22, 2026, 6:48 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	5.49M	1.9M	1.59M	12.5M	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	280K	1.19M	525K	125K	19K	36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.17M	2.06M	1.89M	n/a	556K	100K	90K
Gross Profit	5.21M	714K	1.06M	12.38M	4.98M	-36K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.17M	-2.06M	-1.89M	n/a	-556K	-100K	-90K
Operating Income	-34.17M	-44.14M	-38.46M	-18.89M	-16.86M	-16.93M	-15.23M	-12.95M	-14.35M	-16.09M	-24.99M	-19.87M	-14.96M	-12.62M	-9.13M	-26.15M	-26.78M	-25.96M	-18.94M	-14.6M	-17.53M	-9.37M
Interest Income	2.27M	2.64M	2.99M	2.2M	2.25M	2.32M	2.57M	2.74M	2.46M	788K	n/a	1.09M	251K	n/a	n/a	1.47M	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-31.92M	-41.49M	-35.89M	-16.7M	-14.41M	-14.62M	-12.65M	-10.22M	-10.25M	-16.65M	-23.87M	-18.88M	-14.73M	-12.67M	-9.13M	-24.68M	-26.66M	-26.14M	-18.93M	-14.59M	-17.53M	-19.71M
Net Income	-31.92M	-41.49M	-35.9M	-16.7M	-14.91M	-14.62M	-12.65M	-10.22M	-10.25M	-16.65M	-23.69M	-18.88M	-14.73M	-12.67M	-9.43M	-24.68M	-26.66M	-26.14M	-18.93M	-14.59M	-17.53M	-19.71M
Selling & General & Admin	39.38M	44.85M	39.53M	27.47M	12.78M	11.08M	9.36M	6.49M	7.41M	5.55M	5.45M	2.86M	2.32M	2.29M	1.5M	7.85M	6.94M	5.82M	7.74M	5.36M	4.77M	3.9M
Research & Development	n/a	n/a	n/a	3.79M	9.06M	5.82M	5.87M	6.45M	6.95M	10.54M	19.54M	17M	12.64M	10.33M	7.63M	16.13M	17.78M	18.25M	11.21M	8.68M	12.67M	5.38M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	39.38M	44.85M	39.53M	31.26M	21.84M	16.9M	15.23M	12.95M	14.35M	16.09M	24.99M	19.87M	14.96M	12.62M	9.13M	23.99M	24.71M	24.07M	18.94M	14.05M	17.43M	9.28M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	39.66M	46.04M	40.05M	31.39M	21.86M	16.93M	15.23M	12.95M	14.35M	16.09M	24.99M	19.87M	14.96M	12.62M	9.13M	26.15M	26.78M	25.96M	18.94M	14.6M	17.53M	9.37M
Income Tax Expense	3K	n/a	2K	n/a	500K	n/a	1K	n/a	n/a	n/a	-179K	n/a	n/a	n/a	303K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	31.37M	31.35M	31.07M	28.54M	28.08M	27.53M	27.49M	27.17M	25.61M	4.72M	8.29M	8.18M	8.11M	7.98M	7.96M	7.89M	7.8M	7.72M	8.29M	8.3M	8M	8.3M
Shares Outstanding (Diluted)	31.37M	31.35M	31.07M	28.54M	28.08M	27.53M	27.49M	27.17M	25.61M	4.72M	8.29M	8.18M	8.11M	7.98M	7.96M	7.89M	7.8M	7.72M	8.29M	8.3M	8M	8.3M
EPS (Basic)	-1.02	-1.32	-1.16	-0.59	-0.53	-0.53	-0.46	-0.38	-0.40	-3.53	-2.77	-2.75	-6.82	-3	-3.09	-3.13	-3.42	-3.39	-2.28	-1.76	-2.19	-2.38
EPS (Diluted)	-1.02	-1.32	-1.16	-0.59	-0.53	-0.53	-0.46	-0.38	-0.40	-3.53	-2.77	-2.75	-6.82	-3	-3.09	-3.13	-3.42	-3.39	-2.28	-1.76	-2.19	-2.38
EBITDA	-31.81M	-41.38M	-35.79M	-16.58M	-14.39M	-14.58M	-12.63M	-10.21M	-10.24M	-16.64M	-23.87M	-18.88M	-14.72M	-12.67M	-9.12M	-22.51M	-24.6M	-24.25M	-18.93M	-14.04M	-17.43M	-19.62M
EBIT	-31.92M	-41.49M	-35.89M	-16.7M	-14.41M	-14.62M	-12.65M	-10.22M	-10.25M	-16.65M	-23.87M	-18.88M	-14.73M	-12.67M	-9.13M	-24.68M	-26.66M	-26.14M	-18.93M	-14.59M	-17.53M	-19.71M
Depreciation & Amortization	110K	111K	107K	125K	19K	36K	25K	10K	18K	5K	4K	4K	4K	3K	3K	2.17M	2.06M	1.89M	n/a	556K	100K	90K